
浏览全部资源
扫码关注微信
1.首都医科大学附属北京中医医院皮肤科,北京 100010
2.北京中医药大学研究生院,北京 100029
Received:14 August 2025,
Published:25 November 2025
移动端阅览
徐佳,石英初.中医药治疗特应性皮炎的现状与展望[J].北京中医药,2025,44(11):1370-1377.
XU Jia,SHI Yingchu.Current status and prospects of traditional Chinese medicine in treating atopic dermatitis[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(11):1370-1377.
徐佳,石英初.中医药治疗特应性皮炎的现状与展望[J].北京中医药,2025,44(11):1370-1377. DOI: 10.16025/j.1674-1307.2025.11.001.
XU Jia,SHI Yingchu.Current status and prospects of traditional Chinese medicine in treating atopic dermatitis[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(11):1370-1377. DOI: 10.16025/j.1674-1307.2025.11.001.
特应性皮炎(AD)为常见的慢性皮肤病,给患者身心及家庭带来沉重负担,中医药基于脏腑辨证、气血津液辨证、三焦辨证,使用口服中药内治法及外用中药、针灸等外治法,在改善AD及共病病情、延长AD复发时间并减少西药不良反应方面具有优势。然而,中医药仍面临临床研究样本量小、疗效评价缺乏标准化、儿童用药依从性低及药物机制不明等挑战。未来需通过大样本研究、客观化诊断标准和剂型优化,推动中医药在AD治疗中的规范化应用。
Atopic dermatitis (AD) is a common chronic skin disease that imposes a heavy burden on patients' physical and mental health as well as their families. Based on syndrome differentiation systems including
Zang–fu
organ differentiation,
qi
-blood-body fluid differentiation, and triple energizer differentiation, traditional Chinese medicine (TCM), through internal treatments such as oral herbal medicine and external therapies including topical herbal applications, acupuncture, and moxibustion, shows advantages in improving AD and its comorbid conditions, prolonging the time to AD recurrence, and reducing adverse reactions to Western medicines. However, TCM still faces challenges, including small sample sizes in clinical studies, a lack of standardized efficacy evaluation, low medication adherence in children, and unclear drug mechanisms. In the future, large-sample studies, objective diagnostic criteria, and optimization of dosage forms are needed to promote the standardized application of TCM in the treatment of AD.
JIN L , GE J , CHENG Y , et al . Worldwide prevalence of atopic dermatitis in children between 2000 and 2021: A systematic analysis [J ] . Ann Allergy Asthma Immunol , 2025 , 134 ( 5 ): 603 - 609, e 6 .
GBD 2021 Asthma and Allergic Diseases Collaborators . Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the global burden of disease study 2021 [J ] . Lancet Respir Med , 2025 , 13 ( 5 ): 425 - 446 .
LIN TL , FAN YH , FAN KS , et al . Psoriasis risk in patients with atopic dermatitis treated with dupilumab [J ] . JAMA Dermatol , 2026 , 161 ( 8 ): 813 - 821 .
ARDERN-JONES MR , BROWN SJ , FLOHR C , et al . An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024 [J ] . Br J Dermatol , 2024 , 191 ( 6 ): 865 - 885 .
PALLER AS , MENDES-BASTOS P , SIEGFRIED E , et al . Upadacitinib in adolescents with moderate to severe atopic dermatitis: analysis of 3 phase 3 randomized clinical trials through 76 weeks [J ] . JAMA Dermatol , 2024 , 160 ( 12 ): 1304 - 1313 .
WU H , ZHU J , YANG N , et al . Atopic dermatitis relapse after treatment discontinuation and predictive factors for relapse: JAK1 inhibitors versus dupilumab [J ] . J Dtsch Dermatol Ges , 2025 , 23 ( 6 ): 702 - 710 .
国家中医药管理局 . ZY/T 001.1–001.9-1994 中医病证诊断疗效标准 [S ] . 南京 : 南京大学出版社 , 1994 .
中华中医药学会皮肤科专业委员会 . 特应性皮炎中医诊疗方案专家共识 [J ] . 中国中西医结合皮肤性病学杂志 , 2013 , 12 ( 1 ): 60 - 61 .
DONG Y , LAU HX , SUAINI N , et al . A machine-learning exploration of the exposome from preconception in early childhood atopic eczema, rhinitis and wheeze development [J ] . Environ Res , 2024 , 250 : 118523 .
FUXENCH ZC , MITRA N , DEL POZO D , et al . In utero or early-in-life exposure to antibiotics and the risk of childhood atopic dermatitis, a population-based cohort study [J ] . Br J Dermatol , 2024 , 191 ( 1 ): 58 - 64 .
BRZOZOWSKA A , PODLECKA D , JANKOWSKA A , et al . Maternal diet during pregnancy and risk of allergic diseases in children up to 7-9 years old from polish mother and child cohort study [J ] . Environ Res , 2022 , 208 : 112682 .
周艺巍 , 徐佳 . 基于"心肾合肤"探讨儿童特应性皮炎的中医证治 [J ] . 北京中医药 , 2024 , 43 ( 9 ): 1061 - 1064 .
李瑞欣 , 王萍 , 徐佳 . 基于"水火既济"理论探讨从心肾论治儿童特应性皮炎 [J ] . 北京中医药 , 2024 , 43 ( 4 ): 409 - 412 .
周艺巍 . 滋水清心饮对DNCB诱导的BALB/c小鼠特应性皮炎模型调控作用评价研究 [D ] . 北京 : 北京中医药大学 , 2024 .
马雪宁 , 张君成 , 于腾 , 等 . 地黄饮通过调控JAK1/STAT3信号通路治疗特应性皮炎小鼠的作用机制 [J ] . 中国实验方剂学杂志 , 2024 , 30 ( 10 ): 11 - 19 .
吕慧青 , 华红 , 郑玮清 , 等 . 加味滋阴除湿汤治疗小儿特应性皮炎疗效观察及对SCORAD 评分与血清总 IgE 的影响 [J ] . 现代中医临床 , 2016 , 23 ( 6 ): 36 - 38 .
吕慧青 , 冯金环 , 王清玲 , 等 . 育阴化湿汤治疗慢性期特应性皮炎疗效及对IL-4与INF-γ的影响 [J ] . 山东中医药大学学报 , 2016 , 40 ( 6 ): 521 - 523 .
贾金靖 , 林颖 , 莫秀梅 , 等 . 陈达灿教授辨治特应性皮炎经验撷菁 [J ] . 河北中医 , 2021 , 43 ( 1 ): 21 - 24 .
迟慧彦 , 黄尧洲 , 李贻奎 , 等 . 镇心安神法治疗特应性皮炎多中心随机对照研究 [J ] . 中国药业 , 2021 , 30 ( 20 ): 87 - 90 .
赵炳南 . 简明中医皮肤病学 [M ] . 北京 : 中国中医药出版社 , 2014 : 142 .
朱慧婷 , 尚宝令 , 李伯华 , 等 . 健脾润肤汤治疗特应性皮炎脾虚证全身症状临床疗效观察 [J ] . 时珍国医国药 , 2016 , 27 ( 10 ): 2455 - 2457 .
朱慧婷 , 王燕 , 刘欣 , 等 . 健脾润肤汤对人角质形成细胞丝聚蛋白和Caspase-14表达的影响 [J ] . 中华中医药杂志 , 2024 , 39 ( 12 ): 6714 - 6717 .
连一帆 . 健脾润肤汤联合度普利尤单抗治疗特应性皮炎脾虚血燥证的疗效观察及对血清IgE、EOS的影响 [D ] . 南昌 : 江西中医药大学 , 2024 .
成沈荣 . 针刺干预治疗脾虚湿蕴型特应性皮炎的临床研究 [D ] . 广州 : 广州中医药大学 , 2014 .
马欣 , 黄楚君 , 程子璇 , 等 . 固本化湿方治疗特应性皮炎临床与实验研究 [J ] . 中国中西医结合杂志 , 2025 , 45 ( 5 ): 568 - 577 .
LEE E , KIM JH , LEE SY , et al . Developmental trajectories of atopic dermatitis with multiomics approaches in the infant gut:COCOA birth cohort [J ] . J Allergy Clin Immunol , 2025 , 155 ( 2 ): 557 - 568 .
FAN X , ZANG T , DAI J , et al . The associations of maternal and children's gut microbiota with the development of atopic dermatitis for children aged 2 years [J ] . Front Immunol , 2022 , 13 : 1038876 .
吴亚兰 . 基于肠道免疫炎症失调机制的特应性皮炎脾虚湿蕴证证候基础研究 [D ] . 广州 : 广州中医药大学 , 2024 .
张声生 , 王瑞昕 , 赵鲁卿 , 等 . 中医药治疗功能性胃肠病大有可为 [J ] . 北京中医药 , 2024 , 43 ( 5 ): 448 - 453 .
吴瑞 , 赵祎 , 周松飞 , 等 . 益气温阳化湿法治疗肥胖的内涵探讨 [J ] . 北京中医药 , 2024 , 43 ( 1 ): 66 - 70 .
王湘鹏 , 曾勤 , 杨嘉仪 , 等 . 余仁欢基于肠道菌群学说从脾论治特发性膜性肾病经验 [J ] . 北京中医药 , 2024 , 43 ( 4 ): 381 - 384 .
WANG XZ , HUANG JL , ZHANG J , et al . Fecal microbiota transplantation as a new way for OVA-induced atopic dermatitis of juvenile mice [J ] . Int Immunopharmacol , 2024 , 142 ( Pt B ): 113183 .
刘明强 . 参苓白术散加减治疗脾虚型特应性皮炎的临床疗效及对肠道菌群的影响 [D ] . 南昌 : 江西中医药大学 , 2021 .
杨思敏 . 楂曲消风散对儿童特应性皮炎(湿热蕴结证)的临床疗效及肠道菌群的研究 [D ] . 成都 : 成都中医药大学 , 2023 .
张雪珥 , 叶晟桢 , 郑派 , 等 . 楂曲消风散治疗儿童特应性皮炎湿热蕴结证的临床疗效及其对皮损处皮肤菌群的影响 [J ] . 中医杂志 , 2024 , 65 ( 8 ): 810 - 820 .
陈露 . 陈彤云清心镇肝汤治疗特应性皮炎心肝火旺证的临床疗效观察 [D ] . 北京 : 北京中医药大学 , 2023 .
尹强 , 段行武 , 李丹阳 , 等 . 基于数据挖掘、网络药理和分子对接分析段行武教授治疗成人特应性皮炎用药规律与机制 [J ] . 实用皮肤病学杂志 , 2025 , 18 ( 1 ): 7 - 15 .
陈广山 , 段行武 , 李小婷 , 等 . 基于"肝脾相关"探讨特应性皮炎与睡眠障碍的关系 [J ] . 北京中医药 , 2024 , 43 ( 4 ): 421 - 423 .
朱璐 , 雷水生 , 刘清 , 等 . 从肝脾论治成年女性特应性皮炎 [J ] . 陕西中医 , 2020 , 41 ( 8 ): 1139 - 1143 .
刘海蝶 , 臧晨曦 , 张佩莲 , 等 . 基于"肺主皮毛"理论探讨皮肤屏障功能受损与皮肤病的防治 [J ] . 皮肤病与性病 , 2024 , 46 ( 2 ): 118 - 120 .
武亦阁 , 周光 . “肺-皮毛”功能轴的理论基础和临床价值刍议 [J ] . 中医药学报 , 2023 , 51 ( 6 ): 55 - 58 .
王雪敏 , 崔炳南 . 基于“升降相因”理论从肺论治皮肤病诊疗经验 [J ] . 北京中医药 , 2023 , 42 ( 5 ): 525 - 528 .
鲁宗民 , 秦珊 , 冯鑫鑫 , 等 . 基于“肺主皮毛”理论观察穴位贴敷对哮喘小鼠皮肤及肺中TRPV1 表达的影响 [J ] . 中国中医基础医学杂志 , 2023 , 29 ( 7 ): 1108 - 1113 .
TAMARI M , HEUL AMVER . Neuroimmune mechanisms of type 2 inflammation in the skin and lung [J ] . Allergol Int , 2025 , 74 ( 2 ): 177 - 186 .
杜泽敏 , 熊述清 , 官莹玉 , 等 . 国医大师禤国维治疗儿童特应性皮炎经验 [J ] . 中医学报 , 2020 , 35 ( 1 ): 95 - 98 .
袁慧敏 , 骈雪 , 崔健 , 等 . 探讨麻黄连翘赤小豆汤通过NLRP3细胞焦亡对特应性皮炎样小鼠模型的作用(英文) [J ] . Journal of Traditional Chinese Medical Sciences , 2023 , 10 ( 4 ): 461 - 469,525 .
范子怡 , 孙占学 , 李林仙 , 等 . 从气血津液辨证分期治疗特应性皮炎经验 [J ] . 环球中医药 , 2021 , 14 ( 8 ): 1486 - 1489 .
张慧丽 . 凉血祛湿止痒汤治疗儿童轻中度特应性皮炎血热湿蕴证的临床及实验研究 [D ] . 北京 : 北京中医药大学 , 2024 .
WANG DM , MA X , XU ZA , et al . Qingre Qushi formula suppresses atopic dermatitis via a multi-target mechanism [J ] . J Ethnopharmacol , 2024 , 318 ( Pt A ): 116923 .
WANG S , WANG Y , HAN B , et al . Huanglian ointment alleviates eczema by maintaining the balance of c-Jun and Jun B and inhibiting AGE-RAGE-mediated pro-inflammation signaling pathway [J ] . Phytomedicine , 2022 , 105 : 154372 .
崔晗 , 张天博 , 曲韵 , 等 . 宋艳丽教授基于"治风先治血"探讨芪归润燥方治疗血虚风燥型特应性皮炎的经验总结 [J ] . 中国医药导报 , 2023 , 20 ( 11 ): 131 - 135 .
张爔文 , 黄红 , 郭筱芳 , 等 . 四物消风饮加味联合氯雷他定片治疗特应性皮炎血虚风燥证疗效及对患者Th1/Th2平衡的影响 [J ] . 陕西中医 , 2022 , 43 ( 11 ): 1540 - 1543 .
LIU W , SONG W , LUO Y , et al . Angelica Yinzi alleviates 1-chloro-2,4-dinitrobenzene-induced atopic dermatitis by inhibiting activation of NLRP3 inflammasome and down-regulating the MAPKs/NF-κB signaling pathway [J ] . Saudi Pharm J , 2022 , 30 ( 10 ): 1426 - 1434 .
李苏 , 迮侃 , 蒯仂 , 等 . 化瘀潜阳法辨治成人重度特应性皮炎经验撷英 [J ] . 中华中医药杂志 , 2022 , 37 ( 6 ): 3224 - 3227 .
蔡宛灵 , 杨雪圆 , 王东明 , 等 . 张慧敏基于“玄府-三焦”理论辨治特应性皮炎 [J ] . 吉林中医药 , 2024 , 44 ( 10 ): 1166 - 1170 .
苏跃 , 贾忠武 . 基于三焦辨证体系探究特应性皮炎的中医病机演变 [J ] . 中华中医药杂志 , 2020 , 35 ( 12 ): 6053 - 6055 .
LEE JH , LIM JY , JO EH , et al . Chijabyukpi-tang inhibits pro-inflammatory cytokines and chemokines via the Nrf2/HO-1 signaling pathway in TNF-α/IFN-γ-Stimulated HaCaT Cells and ameliorates 2,4-Dinitrochlorobenzene-induced atopic dermatitis-like skin lesions in mice [J ] . Front Pharmacol , 2020 , 11 : 1018 .
XU Y , CHEN S , ZHANG L , et al . The anti-inflammatory and anti-pruritus mechanisms of Huanglian Jiedu decoction in the treatment of atopic dermatitis [J ] . Front Pharmacol , 2021 , 12 : 735295 .
俞雨欣 , 王萍 , 徐佳 . “水火既济”理论与特应性皮炎瘙痒的诊治思路 [J ] . 皮肤科学通报 , 2024 , 41 ( 3 ): 331 - 336 .
LEBOVIDGE JS , SCHNEIDER LC . Depression and anxiety in patients with atopic dermatitis:recognizing and addressing mental health burden [J ] . Ann Allergy Asthma Immunol , 2025 , 134 ( 5 ): 506 - 515 .
ABUABARA K , KIDD SA , YE M , et al . The impact of stressful childhood life events on atopic dermatitis disease activity and severity [J ] . J Invest Dermatol , 2025 , 145 ( 8 ): 1946 - 1952.e3 .
卢亮 , 刘勇 , 东淳 , 等 . 镇心安神方对辣椒素诱导的背根神经节细胞瞬时受体电位通道蛋白及自噬蛋白表达的影响 [J ] . 中国中医药信息杂志 , 2022 , 29 ( 12 ): 82 - 86 .
刘贤良 . 基于“五脏三不足两有余论”观察三草清心汤治疗儿童特应性皮炎的疗效及对IL-4等因子的影响 [D ] . 南昌 : 江西中医药大学 , 2024 .
李丹阳 , 尹强 , 朱泽兵 , 等 . 疏肝健脾颗粒联合除湿止痒软膏治疗特应性皮炎合并睡眠障碍肝郁脾虚证的随机对照试验 [J ] . 中医杂志 , 2025 , 66 ( 11 ): 1133 - 1139 .
宋红玲 . 加味逍遥散对肝郁脾虚证特应性皮炎患者肠道菌群及TSLP、IL-4、5-HT的影响 [D ] . 乌鲁木齐 : 新疆医科大学 , 2023 .
SILVA DUARTE AJDA , SANABANI SS . Deciphering epigenetic regulations in the inflammatory pathways of atopic dermatitis [J ] . Life Sci , 2024 , 348 : 122713 .
BROUGH HA , NADEAU KC , SINDHER SB , et al . Epicutaneous sensitization in the development of food allergy:what is the evidence and how can this be prevented [J ] . Allergy , 2020 , 75 ( 9 ): 2185 - 2205 .
XIA Y , CAO H , ZHENG J , et al . Claudin-1 mediated tight junction dysfunction as a contributor to atopic march [J ] . Front Immunol , 2022 , 13 : 927465 .
CHOI UE , DENG J , PARTHASARATHY V , et al . Risk factors and temporal associations of progression of the atopic march in children with early-onset atopic dermatitis [J ] . J Am Acad Dermatol , 2025 , 92 ( 4 ): 732 - 740 .
黄家伟 , 吴力群 . 从外通性上焦膜系理论探讨儿童变应性鼻炎-哮喘综合征的治疗 [J ] . 北京中医药 , 2025 , 44 ( 4 ): 527 - 530 .
NIE J , JIANG X , WANG G , et al . Yu-Ping-Feng-San alleviates inflammation in atopic dermatitis mice by TLR4/MyD88/NF-κB pathway [J ] . J Ethnopharmacol , 2024 , 329 : 118092 .
SONG J . Effects of Yu-ping-feng granules combined with loratadine tablets on treatment efficacy and immune factor levels in allergic rhinitis patients [J ] . Am J Transl Res , 2021 , 13 ( 5 ): 5192 - 5199 .
CHAN PH , TO CY , CHAN EY , et al . A randomized placebo-controlled trial of traditional Chinese medicine as an add-on therapy to oral montelukast in the treatment of mild persistent asthma in children [J ] . Complement Ther Med , 2016 , 29 : 219 - 228 .
李博 , 王天园 , 赵国桢 , 等 . 中医药循证叙事临床评价研究概述 [J ] . 北京中医药 , 2023 , 42 ( 5 ): 467 - 469 .
邱瑞瑾 , 万思琦 , 关之玥 , 等 . 核心指标集在循证中医药学研究中的应用价值及前景分析 [J ] . 北京中医药 , 2023 , 42 ( 5 ): 470 - 474 .
郝静 , 向莉 , 王蓬鹏 , 等 . 中西医多学科合作模式诊治儿童肺系过敏性疾病 [J ] . 北京中医药 , 2023 , 42 ( 3 ): 235 - 238 .
商洪才 , 张晓维 . 数智融合促进中医药传承创新发展 [J ] . 北京中医药 , 2023 , 42 ( 5 ): 464 - 466 .
0
Views
1
下载量
0
CSCD
Publicity Resources
Related Articles
Related Author
Related Institution
京公网安备 11010102006710号